90417-53-1

Basic information

• Product Name: 5-Methoxy-3-indazolecarboxylic acid
• Synonyms: 5-METHOXY-3-INDAZOLECARBOXYLIC ACID;5-METHOXY-3-INDOZOLE-CARBOXYLIC ACID;5-METHOXY-1H-INDAZOLE-3-CARBOXYLIC ACID;5-METHOXY-3-(1H)INDAZOLE CARBOXYLIC ACID;5-Methoxy-1H-indazole-3-carboxylic acid ,97%;1H-Indazole-3-carboxylic acid, 5-methoxy-;5-Methoxy-1H-indazole-3-carboxy
• CAS NO: 90417-53-1
• Molecular Formula: C₉H₈N₂O₃
• Molecular Weight: 192.17
• Product Categories: pharmacetical;Indazole
• Mol File: 90417-53-1.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 467.609 °C at 760 mmHg
• Flash Point: 236.602 °C
• Appearance: /
• Density: 1.46 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.689
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 5-Methoxy-3-indazolecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Methoxy-3-indazolecarboxylic acid(90417-53-1)
• EPA Substance Registry System: 5-Methoxy-3-indazolecarboxylic acid(90417-53-1)

Safety Data

• Statements: 22-36
• Safety Statements: 26
• Hazardous Substances Data: 90417-53-1(Hazardous Substances Data)

Usage

Chemical Properties

Brown solid

InChI:InChI=1/C9H8N2O3/c1-14-5-2-3-7-6(4-5)8(9(12)13)11-10-7/h2-4H,1H3,(H,10,11)(H,12,13)

Upstream product

• 39755-95-8 5-methoxyisatine 
• 124-38-9 carbon dioxide 
• 94444-96-9 5-methoxy-1H-indazole 

Downstream Products

• 1452520-17-0 N-({1-[4-(benzyloxy)benzyl]piperidin-4-yl}methyl)-5-methoxy-1H-indazole-3-carboxamide 
• 1452520-19-2 N-{[1-(4-hydroxybenzyl)piperidin-4-yl]methyl}-5-methoxy-1H-indazole-3-carboxamide 
• 1452520-62-5 5-methoxy-N-({1-[2-(3-methyl cyclohexyl)ethyl]piperidin-4-yl}methyl)-1H-indazole-3-carboxamide 
• 1452520-13-6 N-{ [1-(2,4-dichlorobenzyl)piperidin-4-yl]methyl}-5-methoxy-1H-indazole-3-carboxamide 
• 1186507-40-3 1-benzyl-5-methoxy-1H-indazol-3-yl-methanol 
• 865887-16-7 ethyl 5-methoxy-1H-indazole-3-carboxylate 
• 1186507-39-0 benzyl 1-benzyl-5-methoxy-1H-indazole-3-carboxylate 
• 90915-65-4 methyl 5-methoxy-1H-indazole-3-carboxylate 
• 1067190-80-0 5-methoxy-1H-indazole-3-carboxylic acid {2-[4-(3,4-dimethoxy-benzoylamino)-phenyl]-2-methyl-propyl}-amide 
• 882803-11-4 5-hydroxy-1H-indazole-3-carbaldehyde 
• 936132-63-7 3-(2-benzyloxycarbonylamino-2-methoxycarbonyl-vinyl)-5-methoxy-indazole-1-carboxylic acid tert-butyl ester 
• 169789-37-1 5-methoxy-1H-indazole-3-carboxaldehyde 
• 169789-36-0 5-methoxy-1H-indazole-3-methanol 
• 1448314-65-5 5-hydroxy-1-(3-methylbenzoyl)-1H-indazole-3-carboxylic acid ethyl ester 

Relevant articles and documents

ANTICANCER AGENT

An anticancer agent comprising a compound represented by the formula (I) [R1 represents hydrogen atom, hydroxyl group, a C1-6alkoxy group and the like; R2 and R3 represents hydrogen atom, a halogen atom, a C1-6alkyl group and the like; R4 represents hydrogen atom, a C1-6alkyl group, a C1-6alkylsulfonyl group and the like; R5 represents hydrogen atom or a substituent; .... represents a single bond or a double bond; R6 and R7 represents hydrogen atom, a C1-6alkyl group and the like; R8 represents hydrogen atom, a C1-6alkyl group and the like; A represents -O-, -S-, or - CH2-; D represents -C= or -N=; X represents methylene group, -O-, or -CO-; Q represents -N= or -C(R8)=; and Y represents a heterocyclic group or amino group], which shows a superior inhibitory activity against pim-1 kinase.

New practical access to 2-azatryptophans and dehydro derivatives via the Wittig-Horner reaction

The Wittig-Horner reaction of protected 3-formylindazoles 1 with (±)-N-(benzyloxycarbonyl)-α-phosphonoglycine trimethyl ester 2 has been developed as a new practical synthesis of dehydro 2-azatryptophans and amino acid derivatives. The preparation of 5-br

Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.